title: Pain and symptom control in terminally ill children.
abstract: The management of pain in terminally ill pediatric patients has incalculable benefits to patients, their families, and physicians and nurses. A therapeutic management plan is dependent on a thorough understanding of the causes of pain in these patients, on pain assessment, and on the myriad drugs and drug strategies that are essential in pain treatment. Aggressive symptom control of treatment-related side effects can ensure successful implementation of such a plan.
authors.affiliation: Department of Anesthesiology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
authors.forename: K S
authors.initials: KS
authors.lastname: Galloway
authors.forename: M
authors.initials: M
authors.lastname: Yaster
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000777:Anesthetics / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D005767:Gastrointestinal Diseases / Q000628:therapy; D006679:HIV Seropositivity / Q000523:psychology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D009369:Neoplasms / Q000150:complications* / Q000523:psychology; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D010147:Pain Measurement; D010166:Palliative Care; D019452:Terminally Ill / Q000523:psychology*
chemical_list: D000701:Analgesics, Opioid; D000777:Anesthetics; D000929:Antidepressive Agents, Tricyclic; D006634:Histamine H1 Antagonists